Tau levels may also mediate Aβ toxicity and synaptic impairments [22, 23], suggesting that these mechanisms may be intertwined and that both amyloid and tau pathology may play a role in the increased prevalence of epilepsy in AD [3]. This evidence concerns the gene MAPT and amyloidosis.